mitomycin has been researched along with B-Cell Lymphoma in 6 studies
Mitomycin: An antineoplastic antibiotic produced by Streptomyces caespitosus. It is one of the bi- or tri-functional ALKYLATING AGENTS causing cross-linking of DNA and inhibition of DNA synthesis.
mitomycin : A family of aziridine-containing natural products isolated from Streptomyces caespitosus or Streptomyces lavendulae.
Excerpt | Relevance | Reference |
---|---|---|
"He had failure to thrive, and has microcephaly, slight facial dysmorphism, and constitutional short stature but no other phenotypic or hematological manifestations of Fanconi anemia (FA)." | 5.33 | A case report of a patient with microcephaly, facial dysmorphism, mitomycin-c-sensitive lymphocytes, and susceptibility to lymphoma. ( Abella, E; Bakhshi, S; Joenje, H; Madgy, D; Mohamed, AN; Oostra, A; Ravindranath, Y; Schindler, D, 2006) |
"He had failure to thrive, and has microcephaly, slight facial dysmorphism, and constitutional short stature but no other phenotypic or hematological manifestations of Fanconi anemia (FA)." | 1.33 | A case report of a patient with microcephaly, facial dysmorphism, mitomycin-c-sensitive lymphocytes, and susceptibility to lymphoma. ( Abella, E; Bakhshi, S; Joenje, H; Madgy, D; Mohamed, AN; Oostra, A; Ravindranath, Y; Schindler, D, 2006) |
" Specifically, T-lineage cells show a high degree of resistance to the toxic effects of exposure to chemotherapeutic drugs, whereas B-lineage cells show a high degree of sensitivity." | 1.30 | Involvement of gene-specific DNA damage and apoptosis in the differential toxicity of mitomycin C analogs towards B-lineage versus T-lineage lymphoma cells. ( Bloom, SE; Muscarella, DE, 1997) |
"We have investigated the therapeutic effect of CH-271 fusion polypeptide containing both cell-binding domain (C-274) and heparin-binding domain (H-271) of fibronectin in combination with anticancer drugs such as doxorubicin (DOX) or mitomycin C (MMC) on tumor metastasis of different types of tumors." | 1.29 | Antimetastatic effect by anti-adhesion therapy with cell-adhesive peptide of fibronectin in combination with anticancer drugs. ( Azuma, I; Igarashi, Y; Ishizaki, Y; Kato, I; Kobayashi, H; Komazawa, H; Saiki, I; Yoneda, J, 1993) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (50.00) | 18.2507 |
2000's | 2 (33.33) | 29.6817 |
2010's | 1 (16.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kostková, H | 1 |
Etrych, T | 1 |
Ríhová, B | 1 |
Kostka, L | 1 |
Starovoytová, L | 1 |
Kovář, M | 1 |
Ulbrich, K | 1 |
Lau, CB | 1 |
Ho, CY | 1 |
Kim, CF | 1 |
Leung, KN | 1 |
Fung, KP | 1 |
Tse, TF | 1 |
Chan, HH | 1 |
Chow, MS | 1 |
Bakhshi, S | 1 |
Joenje, H | 1 |
Schindler, D | 1 |
Oostra, A | 1 |
Mohamed, AN | 1 |
Madgy, D | 1 |
Ravindranath, Y | 1 |
Abella, E | 1 |
Saiki, I | 1 |
Yoneda, J | 1 |
Kobayashi, H | 1 |
Igarashi, Y | 1 |
Komazawa, H | 1 |
Ishizaki, Y | 1 |
Kato, I | 1 |
Azuma, I | 1 |
Muscarella, DE | 1 |
Bloom, SE | 1 |
Shida, Y | 1 |
Okabe, M | 1 |
Kuroda, T | 1 |
Morimoto, M | 1 |
Ueda, R | 1 |
Takahashi, T | 1 |
6 other studies available for mitomycin and B-Cell Lymphoma
Article | Year |
---|---|
HPMA copolymer conjugates of DOX and mitomycin C for combination therapy: physicochemical characterization, cytotoxic effects, combination index analysis, and anti-tumor efficacy.
Topics: Acrylamides; Animals; Antineoplastic Agents; Carcinoma; Carcinoma, Lewis Lung; Cell Line, Tumor; Cyt | 2013 |
Cytotoxic activities of Coriolus versicolor (Yunzhi) extract on human leukemia and lymphoma cells by induction of apoptosis.
Topics: Antineoplastic Agents; Apoptosis; Cell Division; Cell Line, Tumor; Cell Survival; DNA Fragmentation; | 2004 |
A case report of a patient with microcephaly, facial dysmorphism, mitomycin-c-sensitive lymphocytes, and susceptibility to lymphoma.
Topics: Adolescent; Antineoplastic Agents; Chromosome Aberrations; Disease Susceptibility; Face; Head and Ne | 2006 |
Antimetastatic effect by anti-adhesion therapy with cell-adhesive peptide of fibronectin in combination with anticancer drugs.
Topics: Amino Acid Sequence; Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Adhesion; Dose-Re | 1993 |
Involvement of gene-specific DNA damage and apoptosis in the differential toxicity of mitomycin C analogs towards B-lineage versus T-lineage lymphoma cells.
Topics: Animals; Antineoplastic Agents, Alkylating; Apoptosis; Cell Division; Chickens; DNA; DNA Damage; Lym | 1997 |
In vivo and in vitro antitumor activity of mitomycin C conjugates at 7-N position through a linker containing thiocarbamate bond with CD10 monoclonal antibody.
Topics: Animals; Antibodies, Monoclonal; Antigens, Differentiation; Antigens, Neoplasm; Immunoglobulin G; Ly | 1992 |